98 related articles for article (PubMed ID: 3560437)
1. [Toxicological studies on isepamicin (HAPA-B). IV. Intramuscular subacute toxicity test in the dog].
Nakanishi D; Sano K; Iizuka K; Miura M; Morino T; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3201-44. PubMed ID: 3560437
[TBL] [Abstract][Full Text] [Related]
2. [Toxicological studies on isepamicin (HAPA-B). II. Intramuscular subacute toxicity test in the rat].
Morino T; Endo H; Shiraiwa K; Sano K; Miura M; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3179-200. PubMed ID: 3560436
[TBL] [Abstract][Full Text] [Related]
3. [Toxicological studies on isepamicin (HAPA-B). VII. Chronic intramuscular test in the rat].
Fujii H; Shiraiwa K; Miura M; Morino T; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3245-82. PubMed ID: 3560438
[TBL] [Abstract][Full Text] [Related]
4. [Toxicological studies on isepamicin (HAPA-B). I. Acute toxicity test in the mouse, rat and dog].
Morino T; Sano K; Hara H; Motoyama K; Iizuka K; Hara T; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3164-78. PubMed ID: 3560435
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):188-201. PubMed ID: 3586328
[TBL] [Abstract][Full Text] [Related]
6. [The neuromuscular blocking activity of isepamicin sulfate (HAPA-B) compared with other aminoglycoside antibiotics].
Shinoda Y; Mochizuki D; Hokonohara T; Takayanagi N
Jpn J Antibiot; 1987 Jan; 40(1):136-44. PubMed ID: 3586326
[TBL] [Abstract][Full Text] [Related]
7. [Toxicological study of amikacin following intravenous drip infusion. 1. Acute toxicity in rats, rabbits and dogs, and subacute toxicity in rabbits].
Nakamura K; Akutsu S; Matsumoto H; Samura K; Nakata Y; Asano M; Hirata A; Ishikawa H; Matsuzaki M
Jpn J Antibiot; 1982 Aug; 35(8):2048-67. PubMed ID: 7154250
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). IV. Intramuscular, intravenous and drip intravenous administration of HAPA-B in dogs].
Serizawa K; Shirai M; Endo S; Suzuki T; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):220-31. PubMed ID: 3586331
[TBL] [Abstract][Full Text] [Related]
9. [Effect of isepamicin (HAPA-B) on reproduction. II. Teratological study in rats (intramuscular administration)].
Sasaki M; Kawaguchi K; Yamada H; Kobayashi Y; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3291-310. PubMed ID: 3560440
[TBL] [Abstract][Full Text] [Related]
10. [Toxicological study of amikacin following intravenous drip infusion. 2. Subacute toxicity in dogs after intravenous injection].
Akutsu S; Samura K; Shimamura T; Matsumoto H; Fukushima Y; Asano M; Komatsu H; Matsuzaki M
Jpn J Antibiot; 1982 Aug; 35(8):2069-99. PubMed ID: 7154251
[TBL] [Abstract][Full Text] [Related]
11. [Local irritation study with isepamicin].
Kohira T; Yano J; Kobayashi Y; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3353-68. PubMed ID: 3560444
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). V. Plasma concentrations of HAPA-B in dogs after multiple administrations].
Suzuki T; Shirai M; Endo S; Somiya Y; Sakai A; Nakanishi D; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):232-7. PubMed ID: 3586332
[TBL] [Abstract][Full Text] [Related]
13. [Effect of isepamicin (HAPA-B) on reproduction. IV. Peri- and post-natal study in rats (intramuscular administration)].
Kubota H; Suda M; Yamada H; Kobayashi Y; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3311-28. PubMed ID: 3560441
[TBL] [Abstract][Full Text] [Related]
14. [Effect of isepamicin (HAPA-B) on reproduction. I. Fertility study in rats (intramuscular administration)].
Sasaki M; Kawaguchi K; Yamada H; Kobayashi Y; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3283-90. PubMed ID: 3560439
[TBL] [Abstract][Full Text] [Related]
15. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
Shibata K; Mita I; Shinoda Y; Nakano U; Kinoshita H; Noguchi M; Uzawa T; Sohmiya Y; Takayanagi N
Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). III. Intramuscular, intravenous and drip intravenous administration of HAPA-B in rabbits].
Suzuki T; Somiya Y; Shirai M; Sakai A; Iwasaki M; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):208-19. PubMed ID: 3586330
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). II. Accumulation of HAPA-B after multiple administration in rats].
Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):202-7. PubMed ID: 3586329
[TBL] [Abstract][Full Text] [Related]
18. [Safety evaluation of micronomicin. I. Subacute and chronic toxicity in dogs].
Hara T; Nishikawa S; Miyazaki H; Ohguro Y
Jpn J Antibiot; 1983 Jan; 36(1):150-73. PubMed ID: 6842822
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic fate of 14C-isepamicin sulfate (14C-HAPA-B) in rats. I. Absorption, distribution, metabolism and excretion after a single intramuscular and intravenous administration].
Iwasaki M; Serizawa K; Suzuki T; Morishita M; Takahashi T; Muranishi S
Jpn J Antibiot; 1987 Jan; 40(1):239-52. PubMed ID: 3586333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
